{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T03:54:02Z","timestamp":1778212442558,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00415-019-09310-3","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T07:02:33Z","timestamp":1555657353000},"page":"1809-1815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Update on narcolepsy"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-0942","authenticated-orcid":false,"given":"P. J.","family":"Reading","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"key":"9310_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/sleep\/25.2.197","volume":"25","author":"MH Silber","year":"2002","unstructured":"Silber MH, Krahn LE, Olson EJ, Pankratz VS (2002) The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 25:197\u2013202","journal-title":"Sleep"},{"key":"9310_CR2","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1212\/WNL.58.12.1826","volume":"58","author":"MM Ohayon","year":"2002","unstructured":"Ohayon MM, Priest RG, Zulley J et al (2002) Prevalence of narcolepsy symptomology and diagnosis in the European general population. Neurology 58:1826\u20131833","journal-title":"Neurology"},{"key":"9310_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.sleep.2014.01.015","volume":"15","author":"MJ Thorpy","year":"2014","unstructured":"Thorpy MJ, Krieger AC (2014) Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med 15:502\u2013507","journal-title":"Sleep Med"},{"key":"9310_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","volume":"98","author":"L Lin","year":"1999","unstructured":"Lin L, Faraco J, Li R et al (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365\u2013376","journal-title":"Cell"},{"key":"9310_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino S, Ripley B, Overeem S et al (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39\u201340","journal-title":"Lancet"},{"key":"9310_CR6","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","volume":"18","author":"C Peyron","year":"1998","unstructured":"Peyron C, Tighe DK, van der Pol AN et al (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996\u201310015","journal-title":"J Neurosci"},{"key":"9310_CR7","doi-asserted-by":"publisher","first-page":"11395","DOI":"10.1038\/ncomms11395","volume":"7","author":"JA Gonzalez","year":"2016","unstructured":"Gonzalez JA, Iordanidou P, Strom M et al (2016) Awake dynamics and brain-wide inputs of hypothalamic MCH and orexin networks. Nat Commun 7:11395","journal-title":"Nat Commun"},{"key":"9310_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neuropharm.2012.02.004","volume":"63","author":"JA Parker","year":"2012","unstructured":"Parker JA, Bloom SR (2012) Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology 63:18\u201330","journal-title":"Neuropharmacology"},{"key":"9310_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1517\/17460441.2012.651454","volume":"7","author":"AK Herran-Arita De la","year":"2012","unstructured":"De la Herran-Arita AK, Drucker-Colin R (2012) Models for narcolepsy with cataplexy drug discovery. Expert Opin Drug Discov 7:155\u2013164","journal-title":"Expert Opin Drug Discov"},{"key":"9310_CR10","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1093\/brain\/awt277","volume":"136","author":"F Pizza","year":"2015","unstructured":"Pizza F, Franceschini C, Peltola H et al (2015) Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain 136:3787\u20133795","journal-title":"Brain"},{"key":"9310_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0097-x","author":"CE Mahoney","year":"2018","unstructured":"Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE (2018) The neurobiological basis of narcolepsy. Nat Rev Neurosci. \n                    https:\/\/doi.org\/10.1038\/s41583-018-0097-x","journal-title":"Nat Rev Neurosci"},{"key":"9310_CR12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(99)80023-3","volume":"354","author":"S Overeem","year":"1999","unstructured":"Overeem S, Lammers GJ, van Dijk JG (1999) Weak with laughter. Lancet 354:838","journal-title":"Lancet"},{"key":"9310_CR13","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.5665\/sleep.6222","volume":"39","author":"RJ Holst van","year":"2016","unstructured":"van Holst RJ, van der Cruijsen L, van Mierlo P et al (2016) Aberrant food choices after satiation in human orexin-deficient narcolepsy type 1. Sleep 39:1951\u20131959","journal-title":"Sleep"},{"key":"9310_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/sleep\/19.1.75","volume":"19","author":"GJ Lammers","year":"1996","unstructured":"Lammers GJ, Pijl H, Iestra J et al (1996) Spontaneous food choice in narcolepsy. Sleep 19:75\u201376","journal-title":"Sleep"},{"key":"9310_CR15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(05)74704-8","volume":"355","author":"A Schuld","year":"2000","unstructured":"Schuld A, Hebebrand J, Geller F, Pollmacher T (2000) Increased body-mass index in patients with narcolepsy. Lancer 355:1275","journal-title":"Lancer"},{"key":"9310_CR16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/sleep\/30.10.1267","volume":"30","author":"D Chabas","year":"2007","unstructured":"Chabas D, Foulon C, Gonzalez J et al (2007) Eating disorder and metabolism in narcoleptic patients. Sleep 30:1267\u20131273","journal-title":"Sleep"},{"key":"9310_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5665\/sleep.2366","volume":"36","author":"F Poli","year":"2013","unstructured":"Poli F, Pizza F, Mignot E et al (2013) High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep 36:175\u2013181","journal-title":"Sleep"},{"key":"9310_CR18","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1523\/JNEUROSCI.23-08-03106.2003","volume":"23","author":"D Georgescu","year":"2003","unstructured":"Georgescu D, Zachariou V, Barrot M et al (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23:3106\u20133111","journal-title":"J Neurosci"},{"key":"9310_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.biopsych.2008.03.006","volume":"64","author":"R Sharf","year":"2008","unstructured":"Sharf R, Sarhan M, Dileone RJ (2008) Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 64:175\u2013183","journal-title":"Biol Psychiatry"},{"key":"9310_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00213-010-2127-x","volume":"215","author":"JR Shoblock","year":"2011","unstructured":"Shoblock JR, Welty N, Alusiio L et al (2011) Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychpharmacology 215:191\u2013203","journal-title":"Psychpharmacology"},{"key":"9310_CR21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5664\/JCSM.1076","volume":"7","author":"A Dimitrova","year":"2011","unstructured":"Dimitrova A, Fronczek R, van der Ploeg J et al (2011) Reward-seeking behaviour in human narcolepsy. J Clin Sleep Med 7:293\u2013300","journal-title":"J Clin Sleep Med"},{"key":"9310_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.sleep.2013.03.002","volume":"14","author":"MM Ohayon","year":"2013","unstructured":"Ohayon MM (2013) Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med 14:488\u2013492","journal-title":"Sleep Med"},{"key":"9310_CR23","volume-title":"The international classification of sleep disorders: diagnostic and coding manual","author":"The American Academy of Sleep Medicine","year":"2012","unstructured":"The American Academy of Sleep Medicine (2012) The international classification of sleep disorders: diagnostic and coding manual, 3rd edn. AASM, Chicago","edition":"3"},{"key":"9310_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11910-011-0178-y","volume":"11","author":"T Kayabashi","year":"2011","unstructured":"Kayabashi T, Sagawa Y, Takemura F et al (2011) The pathophysiologic basis of secondary narcolepsy and hypersomnia. Curr Neurol Neurosci Rep 11:235\u2013241","journal-title":"Curr Neurol Neurosci Rep"},{"key":"9310_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.sleep.2011.05.007","volume":"12","author":"YK Wing","year":"2011","unstructured":"Wing YK, Chen L, Lam SP et al (2011) Familial aggregation of narcolepsy. Sleep Med 12:947\u2013951","journal-title":"Sleep Med"},{"key":"9310_CR26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron C, Faraco J, Rogers W et al (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991\u2013997","journal-title":"Nat Med"},{"key":"9310_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5665\/sleep.3300","volume":"37","author":"M Taft","year":"2014","unstructured":"Taft M, Hor H, Dauvilliers Y et al (2014) DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 37:19\u201325","journal-title":"Sleep"},{"key":"9310_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1399-0039.1998.tb02952.x","volume":"51","author":"Z Pelin","year":"1998","unstructured":"Pelin Z, Guilleminault C, Risch N et al (1998) HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group. Tissue Antigens 51:96\u2013100","journal-title":"Tissue Antigens"},{"key":"9310_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajhg.2014.12.010","volume":"96","author":"HM Ollila","year":"2015","unstructured":"Ollila HM, Ravel JM, Han F et al (2015) HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet 96:136\u2013146","journal-title":"Am J Hum Genet"},{"key":"9310_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ana.22587","volume":"70","author":"F Han","year":"2011","unstructured":"Han F, Lin L, Warby SC et al (2011) Narcolepsy onset is seasonal and increased following the H1N1 pandemic in China. Ann Neurol 70:410\u2013417","journal-title":"Ann Neurol"},{"key":"9310_CR31","doi-asserted-by":"publisher","first-page":"e33732","DOI":"10.1371\/journal.pone.0033723","volume":"7","author":"M Partinen","year":"2012","unstructured":"Partinen M, Saarenpaa-Heikkila O, Ilveskoski I et al (2012) Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 7:e33732","journal-title":"PLoS One"},{"key":"9310_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","volume":"38","author":"TO Sarkanen","year":"2018","unstructured":"Sarkanen TO, Alakuijala APE, Dauvilliers YA, Partinenen MM (2018) Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis. Sleep Med Rev 38:177\u2013186","journal-title":"Sleep Med Rev"},{"key":"9310_CR33","doi-asserted-by":"publisher","first-page":"E12323","DOI":"10.1073\/pnas.1818150116","volume":"115","author":"G Luo","year":"2018","unstructured":"Luo G, Ambati A, Lin L et al (2018) Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc Natl Acad Sci USA 115:E12323\u2013E12332","journal-title":"Proc Natl Acad Sci USA"},{"key":"9310_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/sleep\/29.5.601","volume":"29","author":"TE Scammell","year":"2006","unstructured":"Scammell TE (2006) The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy. Sleep 29:633\u2013638","journal-title":"Sleep"},{"key":"9310_CR35","doi-asserted-by":"publisher","first-page":"e0187305","DOI":"10.1371\/journal.pone.0187305","volume":"12","author":"G Luo","year":"2017","unstructured":"Luo G, Lin L, Jacob L et al (2017) Absence of anti-hypocretin receptor 2 autoantibodies in post pandremix narcolepsy cases. PLoS One 12:e0187305","journal-title":"PLoS One"},{"key":"9310_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/d41586-018-06666-w","volume":"562","author":"RS Liblau","year":"2018","unstructured":"Liblau RS (2018) Put to sleep by immune cells. Nature 562:46\u201348","journal-title":"Nature"},{"key":"9310_CR37","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1073\/pnas.0308458100","volume":"101","author":"C Siebald","year":"2004","unstructured":"Siebald C, Hansen BE, Wyer JR et al (2004) Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers string susceptibility to narcolepsy. Proc Natl Acad Sci USA 101:1999\u20132004","journal-title":"Proc Natl Acad Sci USA"},{"key":"9310_CR38","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ng.372","volume":"41","author":"J Hallmayer","year":"2009","unstructured":"Hallmayer J, Faraco J, Lin L et al (2009) Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 41:708\u2013711","journal-title":"Nat Genet"},{"key":"9310_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","volume":"562","author":"D Latorre","year":"2018","unstructured":"Latorre D, Kallweit U, Armentani E et al (2018) T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562:63\u201368","journal-title":"Nature"},{"key":"9310_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsw010","author":"D Lopez","year":"2017","unstructured":"Lopez R, Barateau L, Evangelista E et al (2017) Temporal changes in the cerebrospinal fluid level of hypocretin-1 and histamine in narcolepsy. Sleep. \n                    https:\/\/doi.org\/10.1093\/sleep\/zsw010","journal-title":"Sleep"},{"key":"9310_CR41","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1212\/WNL.0000000000001051","volume":"83","author":"F Pizza","year":"2014","unstructured":"Pizza F, Vandi S, Liguori R et al (2014) Primary progressive narcolepsy type 1: the other side of the coin. Neurology 83:2189\u20132190","journal-title":"Neurology"},{"key":"9310_CR42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1037\/neu0000322","volume":"31","author":"LA Walker","year":"2017","unstructured":"Walker LA, Bourque P, Smith AM, Warman Chardon J (2017) Autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCA-DN) associated with progressive cognitive and behavioural deterioration. Neuropsychology 31:292\u2013303","journal-title":"Neuropsychology"},{"key":"9310_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/jsr.12468","volume":"26","author":"T Roth","year":"2017","unstructured":"Roth T, Dauvilliers Y, Guinta D et al (2017) Effect of sodium oxybate on disrupted nighttime sleep in patiens with narcolepsy. J Sleep Res 26:407\u2013414","journal-title":"J Sleep Res"},{"key":"9310_CR44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5664\/jcsm.2048","volume":"15","author":"MK Alshaikh","year":"2012","unstructured":"Alshaikh MK, Tricco AC, Tashkandi M et al (2012) Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis. J Clin Sleep Med 15:451\u2013458","journal-title":"J Clin Sleep Med"},{"key":"9310_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/NSS.S103462","volume":"9","author":"MW Calik","year":"2017","unstructured":"Calik MW (2017) Update on the treatment of narcolepsy: clinical efficacy of pitolisant. Nat Sci Sleep 9:127\u2013133","journal-title":"Nat Sci Sleep"},{"key":"9310_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S1474-4422(16)30333-7","volume":"16","author":"Z Szakacs","year":"2017","unstructured":"Szakacs Z, Dauvilliers Y, Mikhaylov V et al (2017) Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 16:200\u2013207","journal-title":"Lancet Neurol"},{"key":"9310_CR47","first-page":"1","volume":"2","author":"VC Abad","year":"2018","unstructured":"Abad VC, Guilleminault C (2018) Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea. Expert Rev Respir Med 2:1\u201313","journal-title":"Expert Rev Respir Med"},{"issue":"114","key":"9310_CR48","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1073\/pnas.1700499114","volume":"30","author":"Y Irukayama-Tomobe","year":"2017","unstructured":"Irukayama-Tomobe Y, Ogawa Y, Tominaga H et al (2017) Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models. Proc Natl Acad Sci USA 30(114):5731\u20135736","journal-title":"Proc Natl Acad Sci USA"},{"key":"9310_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/13543784.2018.1459561","volume":"27","author":"S Takenoshita","year":"2018","unstructured":"Takenoshita S, Sakai N, Chiba Y et al (2018) An overview of hypocretin based therapy in narcolepsy. Expert Opin Investig Drugs 27:389\u2013406","journal-title":"Expert Opin Investig Drugs"},{"key":"9310_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/sleep\/32.2.175","volume":"32","author":"S Nishino","year":"2009","unstructured":"Nishino S, Sakurai E, Nevsimalova S et al (2009) Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 32:175\u2013180","journal-title":"Sleep"},{"key":"9310_CR51","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.celrep.2014.03.055","volume":"7","author":"C Schone","year":"2014","unstructured":"Schone C, Aspergis-Schoute J, Sakurai T et al (2014) Coreleased orexin and glutamate evoke nonredundant spike outputs and computations in histamine neurons. Cell Rep 7:687\u2013704","journal-title":"Cell Rep"},{"key":"9310_CR52","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1046\/j.1471-4159.2002.01141.x","volume":"82","author":"IM Reti","year":"2002","unstructured":"Reti IM, Reddy R, Worley PF, Baraban JM (2002) Selective expression of Narp, a secreted neuronal pentraxin, in orexin neurons. J Neurochem 82:1561\u20131565","journal-title":"J Neurochem"},{"key":"9310_CR53","doi-asserted-by":"publisher","first-page":"RC168","DOI":"10.1523\/JNEUROSCI.21-19-j0003.2001","volume":"21","author":"TC Chou","year":"2001","unstructured":"Chou TC, Lee CE, Lu J et al (2001) Orexin (hypocretin) neurons contain dynorphin. J Neurosci 21:RC168","journal-title":"J Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09310-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09310-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09310-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:29:31Z","timestamp":1587166171000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09310-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["9310"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09310-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author has no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}